Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Andrew Johnston

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|April 23, 2004
Does bupropion have advantages over other medical therapies in the cessation of smoking?Serena Tonstad, J Andrew Johnston
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|July 29, 2006
Cardiovascular risks associated with smoking: a review for cliniciansSerena Tonstad, J Andrew Johnston
American Journal of Health Behavior|October 16, 2004
Bupropion SR for relapse prevention: a "slips-allowed" analysisMichael J Durcan, J Andrew Johnston, Jonathan White, et al.
Journal of Clinical Psychopharmacology|September 16, 2006
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerabilityMichael E Thase, Anita H Clayton, Barbara R Haight, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 20, 2005
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XLMaurizio Fava, A John Rush, Michael E Thase, et al.
Clinical Therapeutics|May 23, 2002
The effect of bupropion sustained-release on cigarette craving after smoking cessationMichael J Durcan, Greg Deener, Jonathan White, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 15, 2003
Targeting smokers at increased risk for relapse: treating women and those with a history of depressionStevens S Smith, Douglas E Jorenby, Scott J Leischow, et al.
American Journal of Health Behavior|May 23, 2002
Impact of prior nicotine replacement therapy on smoking cessation efficacyMichael J Durcan, Jonathan White, Douglas E Jorenby, et al.
Addictive Behaviors|August 22, 2002
Bupropion for pharmacologic relapse prevention to smoking: predictors of outcomeRichard D Hurt, Troy D Wolter, Nancy Rigotti, et al.
American Journal of Preventive Medicine|May 4, 2002
Effects of gender on relapse prevention in smokers treated with bupropion SRDavid Gonzales, Wendy Bjornson, Michael J Durcan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|April 23, 2004
Does bupropion have advantages over other medical therapies in the cessation of smoking?Serena Tonstad, J Andrew Johnston
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|July 29, 2006
Cardiovascular risks associated with smoking: a review for cliniciansSerena Tonstad, J Andrew Johnston
American Journal of Health Behavior|October 16, 2004
Bupropion SR for relapse prevention: a "slips-allowed" analysisMichael J Durcan, J Andrew Johnston, Jonathan White, et al.
Journal of Clinical Psychopharmacology|September 16, 2006
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerabilityMichael E Thase, Anita H Clayton, Barbara R Haight, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 20, 2005
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XLMaurizio Fava, A John Rush, Michael E Thase, et al.
Clinical Therapeutics|May 23, 2002
The effect of bupropion sustained-release on cigarette craving after smoking cessationMichael J Durcan, Greg Deener, Jonathan White, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 15, 2003
Targeting smokers at increased risk for relapse: treating women and those with a history of depressionStevens S Smith, Douglas E Jorenby, Scott J Leischow, et al.
American Journal of Health Behavior|May 23, 2002
Impact of prior nicotine replacement therapy on smoking cessation efficacyMichael J Durcan, Jonathan White, Douglas E Jorenby, et al.
Addictive Behaviors|August 22, 2002
Bupropion for pharmacologic relapse prevention to smoking: predictors of outcomeRichard D Hurt, Troy D Wolter, Nancy Rigotti, et al.
American Journal of Preventive Medicine|May 4, 2002
Effects of gender on relapse prevention in smokers treated with bupropion SRDavid Gonzales, Wendy Bjornson, Michael J Durcan, et al.
Pageof 2